Lassen U, Henrik Jensen L, Sorensen M, Rohrberg KS, Ujmajuridze Z, Jakobsen A. A Phase I–II dose escalation study of fixed-dose rate gemcitabine, oxaliplatin and capecitabine every two weeks in advanced cholangiocarcinomas. AO [Internet]. 2011 Apr. 1 [cited 2025 Feb. 17];50(3):448-54. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/32055